Dipeptidyl peptidase IV deficiency increases susceptibility to angiotensin-converting enzyme inhibitor–induced peritracheal edema
Open Access
- 26 May 2007
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 120 (2), 403-408
- https://doi.org/10.1016/j.jaci.2007.04.012
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trialThe Lancet, 2005
- Incidence and Characteristics of Angioedema Associated With EnalaprilArchives of Internal Medicine, 2005
- Dipeptidyl Peptidase IV Activity in Patients With ACE-Inhibitor-Associated AngioedemaHypertension, 2002
- Neurokinin mediation of edema and inflammationNeuropeptides, 2000
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic NephropathyNew England Journal of Medicine, 1993
- Differential processing of substance P and neurokinin A by plasma dipeptidyl(amino)peptidase IV, aminopeptidase M and angiotensin converting enzymePeptides, 1991
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Prekallikrein Activation and High-Molecular-Weight Kininogen Consumption in Hereditary AngioedemaNew England Journal of Medicine, 1983
- Substance P and [Leu]enkephalin are hydrolyzed by an enzyme in pig caudate synaptic membranes that is identical with the endopeptidase of kidney microvilli.Proceedings of the National Academy of Sciences, 1983